BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33072506)

  • 1. Efficacy of lycopene in management of Oral Submucous Fibrosis- A systematic review and meta-analysis.
    Gupta N; Kalaskar A; Kalaskar R
    J Oral Biol Craniofac Res; 2020; 10(4):690-697. PubMed ID: 33072506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effectiveness of lycopene in the management of oral submucous fibrosis (OSMF): A 3-years follow-up study.
    Arakeri G; Patil S; Maddur N; Rao Us V; Subash A; Patil S; Gao S; Brennan PA
    J Oral Pathol Med; 2020 Sep; 49(8):803-808. PubMed ID: 32652683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Therapeutic Efficacy of Different Treatment Modalities in Oral Submucous Fibrosis: A Comparative Study.
    Tp B; T AG; Varghese M; Raghavan R; Vm MN; Pius A
    J Contemp Dent Pract; 2019 Mar; 20(3):390-394. PubMed ID: 31204333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Lycopene in the Treatment of Oral Submucous Fibrosis: A Meta-analysis of Randomized Controlled Trials.
    Guo J; Xie H; Wu H; Liang M
    J Evid Based Dent Pract; 2020 Dec; 20(4):101471. PubMed ID: 33303091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antioxidant treatments in patients with oral submucous fibrosis: A systematic review.
    PĂ©rez-Leal M; Lanciano F; Flacco N; Estornut C; Carceller MC
    J Oral Pathol Med; 2024 Jan; 53(1):31-41. PubMed ID: 38155549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study to evaluate the efficacy of lycopene and curcumin in oral submucous fibrosis patients: A randomized clinical trial.
    Saran G; Umapathy D; Misra N; Channaiah SG; Singh P; Srivastava S; Shivakumar S
    Indian J Dent Res; 2018; 29(3):303-312. PubMed ID: 29900913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colchicine in the Management of Oral Submucous Fibrosis: A Systematic Review, Meta-analysis, and GRADE-Based Assessment of Certainty of Evidence.
    Rai A; Kumar A; Shree P; Haque ZU; Kumari S; Yadav SP; Mahuli SA; Shamsi S
    Indian J Otolaryngol Head Neck Surg; 2023 Dec; 75(4):4125-4136. PubMed ID: 37974771
    [No Abstract]   [Full Text] [Related]  

  • 8. Turmeric in the management of oral submucous fibrosis: A systematic review and meta-analysis.
    Rai A; Kumar N; Sharma S; Parveen S; Rasheed A
    J Cancer Res Ther; 2021; 17(2):327-335. PubMed ID: 34121673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Efficacy of Lycopene and Lycopene-Hyaluronidase Combination in the Treatment of Oral Submucous Fibrosis.
    Johny J; Bhagvandas SC; Mohan SP; Punathil S; Moyin S; Bhaskaran MK
    J Pharm Bioallied Sci; 2019 May; 11(Suppl 2):S260-S264. PubMed ID: 31198349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An overview of effect of lycopene and curcumin in oral leukoplakia and oral submucous fibrosis.
    Ahmad T; Khan I; Rizvi MM; Saalim M; Manzoor N; Sultana A
    Natl J Maxillofac Surg; 2021; 12(3):316-323. PubMed ID: 35153425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Efficacy of Interventions for the Management of Oral Submucous Fibrosis: A Systematic Review and Network Meta-Analysis.
    Gopinath D; Hui LM; Veettil SK; Balakrishnan Nair A; Maharajan MK
    J Pers Med; 2022 Aug; 12(8):. PubMed ID: 36013221
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of therapeutic response of lycopene and curcumin in oral submucous fibrosis: A randomized controlled trial.
    Piyush P; Mahajan A; Singh K; Ghosh S; Gupta S
    Oral Dis; 2019 Jan; 25(1):73-79. PubMed ID: 30059188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicinal management of oral submucous fibrosis in the past decade- A systematic review.
    More CB; Jatti Patil D; Rao NR
    J Oral Biol Craniofac Res; 2020; 10(4):552-568. PubMed ID: 32939334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the effect of newer antioxidant lycopene in the treatment of oral submucous fibrosis.
    Karemore TV; Motwani M
    Indian J Dent Res; 2012; 23(4):524-8. PubMed ID: 23257490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effectiveness of medicinal interventions for oral submucous fibrosis: A network meta-analysis.
    Rai A; Shrivastava PK; Kumar A; Kumar A; Prasad K; Shakeel S; Ul Haque Z
    J Stomatol Oral Maxillofac Surg; 2023 Jun; 124(3):101423. PubMed ID: 36781110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plant leads for mitigation of oral submucous fibrosis: Current scenario and future prospect.
    Pal S; Sharma D; Yadav NP
    Oral Dis; 2024 Mar; 30(2):80-99. PubMed ID: 36565439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Efficacy of ErCr:YSGG Laser Fibrotomy in Management of Moderate Oral Submucous Fibrosis: A Preliminary Study.
    Chaudhry Z; Gupta SR; Oberoi SS
    J Maxillofac Oral Surg; 2014 Sep; 13(3):286-94. PubMed ID: 25018602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mast cell expression in oral submucous fibrosis: A systematic review and metanalysis.
    Gharote H; Bhowate R
    J Clin Exp Dent; 2023 Jul; 15(7):e571-e577. PubMed ID: 37519326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of Life in Oral Submucous Fibrosis: A Systematic Review.
    Chaudhry K; Khatana S; Bali R; Kaur A; Dutt N
    J Maxillofac Oral Surg; 2022 Mar; 21(1):14-24. PubMed ID: 35400917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug treatment for oral submucous fibrosis: an update.
    Chen X; Xie H; Guo J
    BMC Oral Health; 2023 Oct; 23(1):748. PubMed ID: 37828490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.